Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Show more...
CEO
Blaise Coleman
Karyawan
2931
Negara
IE
ISIN
IE00BJ3V9050
WKN
000A1XE6M
Pencatatan
0 Comments
Bagikan pendapatmu
FAQ
Berapa harga saham Endo International hari ini?▼
Harga saat ini dari ENDPQ adalah $0 USD — naik sebesar +0% dalam 24 jam terakhir. Pantau kinerja harga saham Endo International lebih dekat di grafik.
Apa simbol saham Endo International?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Endo International diperdagangkan dengan simbol ENDPQ.
Berapa pendapatan Endo International tahun lalu?▼
Pendapatan Endo International tahun lalu berjumlah 2.01B USD.
Berapa pendapatan bersih Endo International tahun lalu?▼
Pendapatan bersih ENDPQ untuk tahun lalu adalah -2.45B USD.
Berapa jumlah karyawan Endo International?▼
Per April 01, 2026, perusahaan memiliki 2,931 karyawan.
Endo International berada di sektor apa?▼
Endo International beroperasi di sektor Professional, Scientific, and Technical Services.
Kapan Endo International menyelesaikan split saham?▼
Endo International belum melakukan split saham baru-baru ini.
Di mana kantor pusat Endo International?▼
Kantor pusat Endo International berlokasi di Dublin, IE.